应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
AVBP ArriVent BioPharma
交易中 08-21 13:11:06 EDT
29.49
+0.31
+1.06%
最高
29.76
最低
28.97
成交量
10.17万
今开
29.45
昨收
29.18
日振幅
2.69%
总市值
14.54亿
流通市值
9.47亿
总股本
4,931万
成交额
298.56万
换手率
0.32%
流通股本
3,211万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
ArriVent BioPharma签署公开市场销售协议 拟发行至多2.5亿美元普通股
美股速递 · 05-12
ArriVent BioPharma签署公开市场销售协议 拟发行至多2.5亿美元普通股
ArriVent BioPharma宣布新型四价靶向抗体偶联药物ARR-002获IND许可，初期主攻卵巢癌与子宫内膜癌
美股速递 · 05-07
ArriVent BioPharma宣布新型四价靶向抗体偶联药物ARR-002获IND许可，初期主攻卵巢癌与子宫内膜癌
Arrivent Biopharma, Inc.2024财年实现净利润-80.49百万美元，同比减少16.10%
市场透视 · 2025-03-09
Arrivent Biopharma, Inc.2024财年实现净利润-80.49百万美元，同比减少16.10%
Arrivent Biopharma, Inc.盘中异动 大幅下跌5.51%报23.84美元
市场透视 · 2025-02-27
Arrivent Biopharma, Inc.盘中异动 大幅下跌5.51%报23.84美元
Arrivent Biopharma, Inc.盘中异动 大幅跳水7.57%报25.02美元
市场透视 · 2025-02-24
Arrivent Biopharma, Inc.盘中异动 大幅跳水7.57%报25.02美元
Arrivent Biopharma, Inc.盘中异动 股价大涨5.24%报28.00美元
市场透视 · 2025-02-18
Arrivent Biopharma, Inc.盘中异动 股价大涨5.24%报28.00美元
Arrivent Biopharma, Inc.盘中异动 急速下挫5.11%
市场透视 · 2025-02-07
Arrivent Biopharma, Inc.盘中异动 急速下挫5.11%
Arrivent Biopharma, Inc.盘中异动 早盘大幅拉升5.77%报26.77美元
市场透视 · 2025-01-22
Arrivent Biopharma, Inc.盘中异动 早盘大幅拉升5.77%报26.77美元
【乐普生物-B(02157.HK)就创新型ADC MRG007订立独家许可协议】乐普生物-B(02157.HK)发布公告，于2025年1月22日，公司与ArriVent Biopharma, Inc.(该公司于纳斯达克全球市场上市(股票代码：AVBP))订立独家许可协议。据此协议，公司向ArriVent授予独家许可，以在全球范围内(大中华地区除外)开发及商业化集团创新型抗体偶联药物MRG007。
金融界 · 2025-01-22
【乐普生物-B(02157.HK)就创新型ADC MRG007订立独家许可协议】乐普生物-B(02157.HK)发布公告，于2025年1月22日，公司与ArriVent Biopharma, Inc.(该公司于纳斯达克全球市场上市(股票代码：AVBP))订立独家许可协议。据此协议，公司向ArriVent授予独家许可，以在全球范围内(大中华地区除外)开发及商业化集团创新型抗体偶联药物MRG007。
Arrivent Biopharma, Inc.盘中异动 早盘快速上涨5.19%
市场透视 · 2025-01-21
Arrivent Biopharma, Inc.盘中异动 早盘快速上涨5.19%
Arrivent Biopharma, Inc.盘中异动 早盘快速下挫5.18%报23.63美元
市场透视 · 2025-01-16
Arrivent Biopharma, Inc.盘中异动 早盘快速下挫5.18%报23.63美元
Arrivent Biopharma, Inc.盘中异动 急速拉升6.80%
市场透视 · 2025-01-15
Arrivent Biopharma, Inc.盘中异动 急速拉升6.80%
Arrivent Biopharma, Inc.盘中异动 大幅下挫5.06%报25.50美元
市场透视 · 2025-01-10
Arrivent Biopharma, Inc.盘中异动 大幅下挫5.06%报25.50美元
Arrivent Biopharma, Inc.盘中异动 股价大跌5.52%
市场透视 · 2025-01-07
Arrivent Biopharma, Inc.盘中异动 股价大跌5.52%
Arrivent Biopharma, Inc.盘中异动 下午盘快速下跌5.25%
市场透视 · 2024-12-13
Arrivent Biopharma, Inc.盘中异动 下午盘快速下跌5.25%
Arrivent Biopharma, Inc.盘中异动 急速上涨5.35%报28.97美元
市场透视 · 2024-11-27
Arrivent Biopharma, Inc.盘中异动 急速上涨5.35%报28.97美元
Arrivent Biopharma, Inc.2024财年第三财季实现净利润-20.56百万美元，同比减少42.78%
市场透视 · 2024-11-23
Arrivent Biopharma, Inc.2024财年第三财季实现净利润-20.56百万美元，同比减少42.78%
Arrivent Biopharma, Inc.盘中异动 早盘股价大跌5.78%报30.02美元
市场透视 · 2024-11-14
Arrivent Biopharma, Inc.盘中异动 早盘股价大跌5.78%报30.02美元
Arrivent Biopharma, Inc.盘中异动 大幅下挫5.05%报29.88美元
市场透视 · 2024-10-31
Arrivent Biopharma, Inc.盘中异动 大幅下挫5.05%报29.88美元
Arrivent Biopharma, Inc.盘中异动 快速拉升5.03%报31.76美元
市场透视 · 2024-10-25
Arrivent Biopharma, Inc.盘中异动 快速拉升5.03%报31.76美元
加载更多
公司概况
公司名称：
ArriVent BioPharma
所属市场：
NASDAQ
上市日期：
--
主营业务：
Arrivent Biopharma, Inc.于2021年4月14日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，致力于差异化药物的识别、开发和商业化，以解决癌症患者未满足的医疗需求。该公司寻求利用团队深厚的药物开发经验，通过在患有癌症的患者中获得批准和商业化，最大限度地发挥先导开发候选药物呋莫替尼的潜力，并推进一系列新疗法，例如下一代抗体药物偶联物，最初的重点是实体瘤。
发行价格：
--
{"stockData":{"symbol":"AVBP","market":"US","secType":"STK","nameCN":"ArriVent BioPharma","latestPrice":29.49,"timestamp":1787332262459,"preClose":29.18,"halted":0,"volume":101689,"delay":0,"changeRate":0.010623714873200778,"floatShares":32106300,"shares":49307729,"eps":-3.697539,"marketStatus":"交易中","change":0.31,"latestTime":"08-21 13:11:06 EDT","open":29.45,"high":29.755,"low":28.97,"amount":2985631.3426240003,"amplitude":0.026902,"askPrice":29.49,"askSize":23,"bidPrice":29.36,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.697539,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1787342400000},"marketStatusCode":2,"adr":0,"listingDate":1706245200000,"exchange":"NASDAQ","adjPreClose":29.18,"preHourTrading":{"tag":"盘前","latestPrice":29.75,"preClose":29.18,"latestTime":"09:20 EDT","volume":62,"amount":1846.81012,"timestamp":1787318413966,"change":0.57,"changeRate":0.019534,"amplitude":0.130569},"postHourTrading":{"tag":"盘后","latestPrice":29.18,"preClose":29.18,"latestTime":"16:10 EDT","volume":10768,"amount":314210.24,"timestamp":1787256604033,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.400179,"impliedVol":1.185,"impliedVolPercentile":0.5538},"requestUrl":"/m/hq/s/AVBP/","defaultTab":"news","newsList":[{"id":"1122953955","title":"ArriVent BioPharma签署公开市场销售协议 拟发行至多2.5亿美元普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1122953955","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122953955?lang=zh_cn&edition=full","pubTime":"2026-05-12 04:43","pubTimestamp":1778532212,"startTime":"0","endTime":"0","summary":"根据向美国证券交易委员会（SEC）提交的文件，生物制药公司ArriVent BioPharma Inc.已签订一项公开市场销售协议。依据该协议，公司可不时发行并销售其普通股，总金额最高可达2.5亿美元。\n此项安排为公司提供了灵活的融资渠道，使其能够根据市场状况和自身资金需求，选择性地向公开市场发行新股。销售所得款项将用于一般公司用途，可能包括营运资金、研发投入以及其他战略投资。\n通过此类协议，上市公司能够更高效地筹集资金，同时为市场提供持续的股票供应。协议的签署标志着ArriVent BioPharma在资本运作方面迈出了新的一步，旨在支持其未来的业务发展与管线推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189918859","title":"ArriVent BioPharma宣布新型四价靶向抗体偶联药物ARR-002获IND许可，初期主攻卵巢癌与子宫内膜癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1189918859","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189918859?lang=zh_cn&edition=full","pubTime":"2026-05-07 20:02","pubTimestamp":1778155331,"startTime":"0","endTime":"0","summary":"ArriVent BioPharma公司宣布，其研发的新型四价靶向Muc16/Napi2b抗体偶联药物ARR-002已获得新药临床试验申请（IND）许可。该药物研发项目将首先聚焦于卵巢癌和子宫内膜癌的治疗领域。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AVBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518999428","title":"Arrivent Biopharma, Inc.2024财年实现净利润-80.49百万美元，同比减少16.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518999428","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518999428?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:01","pubTimestamp":1741449670,"startTime":"0","endTime":"0","summary":"3月9日，Arrivent Biopharma, Inc.公布财报，公告显示公司2024财年净利润为-80.49百万美元，同比减少16.10%；其中营业收入为0.00美元，每股基本收益为-2.39美元。从资产负债表来看，Arrivent Biopharma, Inc.总负债17.29百万美元，其中短期债务162000.00美元，资产负债比为0.16，流动比率为0.14。机构评级：截至2025年3月9日，当前有4家机构对Arrivent Biopharma, Inc.目标价做出预测，其中目标均价为39.25美元，其中最低目标价为38.00美元，最高目标价为41.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000232abef983c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000232abef983c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514508861","title":"Arrivent Biopharma, Inc.盘中异动 大幅下跌5.51%报23.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514508861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514508861?lang=zh_cn&edition=full","pubTime":"2025-02-27 03:01","pubTimestamp":1740596500,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日03时01分，Arrivent Biopharma, Inc.股票出现波动，股价急速下跌5.51%。Arrivent Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.79%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6517.18%、288.23%、256.28%，振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Organovo Holdings, Inc.，振幅分别为194.07%、81.11%、52.76%。Arrivent Biopharma, Inc.公司简介：ArriVent BioPharma Inc 是一家临床阶段的生物制药公司，致力于识别、开发和商业化差异化药物，以解决癌症患者未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227030140a255338d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227030140a255338d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513419722","title":"Arrivent Biopharma, Inc.盘中异动 大幅跳水7.57%报25.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513419722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513419722?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:32","pubTimestamp":1740407574,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时32分，Arrivent Biopharma, Inc.股票出现异动，股价大幅下跌7.57%。Arrivent Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Arrivent Biopharma, Inc.公司简介：ArriVent BioPharma Inc 是一家临床阶段的生物制药公司，致力于识别、开发和商业化差异化药物，以解决癌症患者未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223254a25214a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223254a25214a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512165392","title":"Arrivent Biopharma, Inc.盘中异动 股价大涨5.24%报28.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165392","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512165392?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:33","pubTimestamp":1739889194,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时33分，Arrivent Biopharma, Inc.股票出现异动，股价急速拉升5.24%。截至发稿，该股报28.00美元/股，成交量1071股，换手率0.00%，振幅0.00%。Arrivent Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Arrivent Biopharma, Inc.公司简介：ArriVent BioPharma Inc 是一家临床阶段的生物制药公司，致力于识别、开发和商业化差异化药物，以解决癌症患者未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822331496279770&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822331496279770&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509788461","title":"Arrivent Biopharma, Inc.盘中异动 急速下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509788461","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509788461?lang=zh_cn&edition=full","pubTime":"2025-02-07 03:08","pubTimestamp":1738868892,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日03时08分，Arrivent Biopharma, Inc.股票出现异动，股价急速下挫5.11%。Arrivent Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Arrivent Biopharma, Inc.公司简介：ArriVent BioPharma Inc 是一家临床阶段的生物制药公司，致力于识别、开发和商业化差异化药物，以解决癌症患者未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207030812987cb59f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207030812987cb59f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505245007","title":"Arrivent Biopharma, Inc.盘中异动 早盘大幅拉升5.77%报26.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505245007","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505245007?lang=zh_cn&edition=full","pubTime":"2025-01-22 23:15","pubTimestamp":1737558905,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日23时15分，Arrivent Biopharma, Inc.股票出现波动，股价急速拉升5.77%。Arrivent Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Arrivent Biopharma, Inc.公司简介：ArriVent BioPharma Inc 是一家临床阶段的生物制药公司，致力于识别、开发和商业化差异化药物，以解决癌症患者未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122231505a22bbbe4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122231505a22bbbe4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505194732","title":"【乐普生物-B(02157.HK)就创新型ADC MRG007订立独家许可协议】乐普生物-B(02157.HK)发布公告，于2025年1月22日，公司与ArriVent Biopharma, Inc.(该公司于纳斯达克全球市场上市(股票代码：AVBP))订立独家许可协议。据此协议，公司向ArriVent授予独家许可，以在全球范围内(大中华地区除外)开发及商业化集团创新型抗体偶联药物MRG007。","url":"https://stock-news.laohu8.com/highlight/detail?id=2505194732","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505194732?lang=zh_cn&edition=full","pubTime":"2025-01-22 08:13","pubTimestamp":1737504821,"startTime":"0","endTime":"0","summary":"乐普生物-B(02157.HK)发布公告，于2025年1月22日，公司与ArriVent Biopharma, Inc.(该公司于纳斯达克全球市场上市(股票代码：AVBP))订立独家许可协议。据此协议，公司向ArriVent授予独家许可，以在全球范围内(大中华地区除外)开发及商业化集团创新型抗体偶联药物MRG007。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/22081347680310.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ADC","AVBP","02157","BK1161","BK4231","BK4080","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505270400","title":"Arrivent Biopharma, Inc.盘中异动 早盘快速上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505270400","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505270400?lang=zh_cn&edition=full","pubTime":"2025-01-21 23:30","pubTimestamp":1737473413,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日23时30分，Arrivent Biopharma, Inc.股票出现波动，股价快速拉升5.19%。Arrivent Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.28%。Arrivent Biopharma, Inc.公司简介：ArriVent BioPharma Inc 是一家临床阶段的生物制药公司，致力于识别、开发和商业化差异化药物，以解决癌症患者未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121233015abb354a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121233015abb354a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503918717","title":"Arrivent Biopharma, Inc.盘中异动 早盘快速下挫5.18%报23.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503918717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503918717?lang=zh_cn&edition=full","pubTime":"2025-01-16 22:40","pubTimestamp":1737038422,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时40分，Arrivent Biopharma, Inc.股票出现波动，股价急速下挫5.18%。截至发稿，该股报23.63美元/股，成交量2415股，换手率0.01%，振幅0.86%。Arrivent Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Arrivent Biopharma, Inc.公司简介：ArriVent BioPharma Inc 是一家临床阶段的生物制药公司，致力于识别、开发和商业化差异化药物，以解决癌症患者未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116224022abad51b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116224022abad51b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503647409","title":"Arrivent Biopharma, Inc.盘中异动 急速拉升6.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503647409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503647409?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951550,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，Arrivent Biopharma, Inc.股票出现波动，股价急速上涨6.80%。Arrivent Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Generation Bio Co.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.07%、54.43%、35.46%，振幅较大的相关个股有Onconetix, Inc.、Klotho Neurosciences, Inc.、Eterna Therapeutics Inc.，振幅分别为14.29%、12.00%、11.55%。Arrivent Biopharma, Inc.公司简介：ArriVent BioPharma Inc 是一家临床阶段的生物制药公司，致力于识别、开发和商业化差异化药物，以解决癌症患者未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223230a222fe2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223230a222fe2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502898794","title":"Arrivent Biopharma, Inc.盘中异动 大幅下挫5.06%报25.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502898794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502898794?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:13","pubTimestamp":1736522004,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时13分，Arrivent Biopharma, Inc.股票出现波动，股价急速下挫5.06%。Arrivent Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为1.39%。Arrivent Biopharma, Inc.公司简介：ArriVent BioPharma Inc 是一家临床阶段的生物制药公司，致力于识别、开发和商业化差异化药物，以解决癌症患者未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110231325a21d189a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110231325a21d189a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501636862","title":"Arrivent Biopharma, Inc.盘中异动 股价大跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501636862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501636862?lang=zh_cn&edition=full","pubTime":"2025-01-07 02:04","pubTimestamp":1736186695,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日02时04分，Arrivent Biopharma, Inc.股票出现波动，股价大幅下挫5.52%。Arrivent Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Arrivent Biopharma, Inc.公司简介：ArriVent BioPharma Inc 是一家临床阶段的生物制药公司，致力于识别、开发和商业化差异化药物，以解决癌症患者未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010702045595fa990f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010702045595fa990f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491353465","title":"Arrivent Biopharma, Inc.盘中异动 下午盘快速下跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491353465","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2491353465?lang=zh_cn&edition=full","pubTime":"2024-12-13 02:52","pubTimestamp":1734029558,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日02时52分，Arrivent Biopharma, Inc.股票出现异动，股价大幅跳水5.25%。Arrivent Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为1.05%。Arrivent Biopharma, Inc.公司简介：ArriVent BioPharma Inc 是一家临床阶段的生物制药公司，致力于识别、开发和商业化差异化药物，以解决癌症患者未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121302523895e93fcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121302523895e93fcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2486988886","title":"Arrivent Biopharma, Inc.盘中异动 急速上涨5.35%报28.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486988886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2486988886?lang=zh_cn&edition=full","pubTime":"2024-11-27 00:57","pubTimestamp":1732640274,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日00时57分，Arrivent Biopharma, Inc.股票出现波动，股价大幅拉升5.35%。截至发稿，该股报28.97美元/股，成交量10.9582万股，换手率0.33%，振幅4.87%。Arrivent Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Arrivent Biopharma, Inc.公司简介：ArriVent BioPharma Inc 是一家临床阶段的生物制药公司，致力于识别、开发和商业化差异化药物，以解决癌症患者未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112700575498e44b97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112700575498e44b97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2485298943","title":"Arrivent Biopharma, Inc.2024财年第三财季实现净利润-20.56百万美元，同比减少42.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485298943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2485298943?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:02","pubTimestamp":1732291375,"startTime":"0","endTime":"0","summary":"11月23日，Arrivent Biopharma, Inc.公布财报，公告显示公司2024财年第三财季净利润为-20.56百万美元，同比减少42.78%；其中营业收入为0.00美元，每股基本收益为-0.61美元。从资产负债表来看，Arrivent Biopharma, Inc.总负债15.22百万美元，其中短期债务157000.00美元，资产负债比为0.20，流动比率为0.20。机构评级：截至2024年11月23日，当前有6家机构对Arrivent Biopharma, Inc.目标价做出预测，其中目标均价为38.33美元，其中最低目标价为36.00美元，最高目标价为41.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000317abd7b930&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000317abd7b930&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483802016","title":"Arrivent Biopharma, Inc.盘中异动 早盘股价大跌5.78%报30.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483802016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483802016?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:48","pubTimestamp":1731595735,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时48分，Arrivent Biopharma, Inc.股票出现异动，股价大幅跳水5.78%。截至发稿，该股报30.02美元/股，成交量7870股，换手率0.02%，振幅4.49%。Arrivent Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Arrivent Biopharma, Inc.公司简介：ArriVent BioPharma Inc 是一家临床阶段的生物制药公司，致力于识别、开发和商业化差异化药物，以解决癌症患者未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224856971a692a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224856971a692a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PULM","BK4007","AVBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2479345700","title":"Arrivent Biopharma, Inc.盘中异动 大幅下挫5.05%报29.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479345700","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2479345700?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:59","pubTimestamp":1730386797,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时59分，Arrivent Biopharma, Inc.股票出现波动，股价大幅下挫5.05%。截至发稿，该股报29.88美元/股，成交量1.7264万股，换手率0.05%，振幅5.24%。Arrivent Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为3.30%。Arrivent Biopharma, Inc.公司简介：ArriVent BioPharma Inc 是一家临床阶段的生物制药公司，致力于识别、开发和商业化差异化药物，以解决癌症患者未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103122595798e3fc21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103122595798e3fc21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2478657509","title":"Arrivent Biopharma, Inc.盘中异动 快速拉升5.03%报31.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478657509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2478657509?lang=zh_cn&edition=full","pubTime":"2024-10-25 00:37","pubTimestamp":1729787869,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日00时37分，Arrivent Biopharma, Inc.股票出现波动，股价大幅拉升5.03%。截至发稿，该股报31.76美元/股，成交量5.6963万股，换手率0.17%，振幅4.18%。Arrivent Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Arrivent Biopharma, Inc.公司简介：ArriVent BioPharma Inc 是一家临床阶段的生物制药公司，致力于识别、开发和商业化差异化药物，以解决癌症患者未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102500374998e3e4c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102500374998e3e4c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AVBP"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arrivent.com","stockEarnings":[{"period":"1week","weight":-0.0273},{"period":"1month","weight":0.0326},{"period":"3month","weight":0.0917},{"period":"6month","weight":0.2692},{"period":"1year","weight":0.5143},{"period":"ytd","weight":0.4503}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0191},{"period":"3month","weight":0.0227},{"period":"6month","weight":0.1061},{"period":"1year","weight":0.1951},{"period":"ytd","weight":0.1183}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arrivent Biopharma, Inc.于2021年4月14日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，致力于差异化药物的识别、开发和商业化，以解决癌症患者未满足的医疗需求。该公司寻求利用团队深厚的药物开发经验，通过在患有癌症的患者中获得批准和商业化，最大限度地发挥先导开发候选药物呋莫替尼的潜力，并推进一系列新疗法，例如下一代抗体药物偶联物，最初的重点是实体瘤。","exchange":"NASDAQ","name":"ArriVent BioPharma","nameEN":"ArriVent BioPharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ArriVent BioPharma(AVBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ArriVent BioPharma(AVBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ArriVent BioPharma,AVBP,ArriVent BioPharma股票,ArriVent BioPharma股票老虎,ArriVent BioPharma股票老虎国际,ArriVent BioPharma行情,ArriVent BioPharma股票行情,ArriVent BioPharma股价,ArriVent BioPharma股市,ArriVent BioPharma股票价格,ArriVent BioPharma股票交易,ArriVent BioPharma股票购买,ArriVent BioPharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ArriVent BioPharma(AVBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ArriVent BioPharma(AVBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}